You just read:

Eiger Announces Breakthrough Therapy Designation Granted by FDA for Lonafarnib in Progeria and Progeroid Laminopathies

News provided by

Eiger BioPharmaceuticals, Inc.

Dec 19, 2018, 08:00 ET